Quantcast

Latest Drugs Stories

2014-09-18 08:28:42

OTTAWA, Sept. 18, 2014 /CNW/ - A new expert panel report, Improving Medicines for Children in Canada, released today by the Council of Canadian Academies, addresses the importance of developing safe and effective medicines for children. Each year about half of Canada's seven million children use at least one prescription drug. Much of this prescribing is done off-label (i.e. the prescription differs from the authorized use), creating potential health risks. Children have historically been...

2014-09-17 12:27:16

DALLAS, Sept. 17, 2014 /PRNewswire-iReach/ -- The abuse of prescription pain medication is the deadliest drug problem facing America, according to a study by the Centers for Disease Control and Prevention (CDC). The CDC reports prescription drugs have a higher overdose rate than heroin and cocaine combined. Physicians are now taking a harder look at their role in this national epidemic and doing something about it by using a new non-narcotic alternative for pain relief after surgery....

2014-09-16 08:29:33

ALPINE, UT, Sept. 16, 2014 /PRNewswire/ - American Biotech Labs, LLC, is pleased to announce the availability of three new silver hydrogel wound-dressing products. The new products will allow American Biotech Labs (ABL) to market in the wound-care market focusing on ultimate sports and fitness, spa and health, and animal markets. The new over-the-counter (OTC) products will have wound-dressing claims for minor cuts, lacerations, abrasions, 1st and 2nd degree burns, and skin...

2014-09-15 16:29:02

Data Presented at the American Society of Bone and Mineral Research 2014 Annual Meeting THOUSAND OAKS, Calif., Sept. 15, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from a new exploratory analysis of the open-label extension study of the pivotal Phase 3 fracture trial, which found that treatment with Prolia(®) (denosumab) for eight years enabled a substantial proportion of women with osteoporosis to achieve non-osteoporotic T-scores (>-2.5) at the lumbar spine and...

2014-09-15 16:28:40

Romosozumab Currently in Phase 3 Clinical Development, Pivotal Data Expected in 2016 THOUSAND OAKS, Calif. and BRUSSELS, Sept. 15, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels:UCB) today announced results from several exploratory analyses of the Phase 2 study evaluating romosozumab in postmenopausal women with low bone mineral density (BMD). Romosozumab is an investigational bone-forming agent that is designed to work by inhibiting the protein sclerostin, thereby...

2014-09-10 08:32:41

Data Include Eight Year Analyses of Bone Mineral Density Results for Prolia® (Denosumab) and Further Evidence for Significant Bone-Building With Romosozumab THOUSAND OAKS, Calif., Sept. 10, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it will present data from multiple Prolia(®) (denosumab) and romosozumab study analyses at the American Society for Bone and Mineral Research (ASBMR) 2014 Annual Meeting being held in Houston, Sept. 12-15, 2014. The data that will be...

2014-09-09 08:33:16

Company Receives Purchase Order for its Rx DrugSAFE Fingerprint Lock-boxes HENDERSON, Nev., Sept. 9, 2014 /PRNewswire/ -- Rx Safes, Inc., the manufacturer of fingerprint recognition home prescription lock-boxes has been named winning bidder of a solicitation issued by the Oklahoma Bureau of Narcotics and Dangerous Drugs Control. The Company has received a Purchase Order issued by the Bureau for 500 units of the Rx DrugSAFE, which will be given to at risk families in the State....

2014-09-08 23:03:55

Industry consolidation will continue to increase the size and clout of PBMs who promote drug therapies as preventative measures and less expensive alternatives to more costly forms of medical care like hospitalizations, thereby boosting prescription medication use and industry revenue. For these reasons, industry research firm IBISWorld has updated a report on the Pharmacy Benefit Management industry in its growing industry report collection. New York, NY (PRWEB) September 08, 2014...

2014-09-08 16:25:38

ST. PAUL, Minn., Sept. 8, 2014 /PRNewswire/ -- Prime Therapeutics, LLC (Prime) has submitted comments to the U.S. Food and Drug Administration (FDA) in support of two citizen petitions on the naming of biosimilar drugs. Biosimilars are medically equivalent versions of biologics, used to treat complex illnesses such as cancer. The citizen petitions were filed in 2013 by the Generic Pharmaceutical Association (GPhA) and Novartis. The petitions urged the FDA to adopt a naming system...

2014-09-03 23:03:07

The NCPA recently wrote to the U.S. House of Representatives and encouraged them to pass a bill that would make great strides in reducing the number of Americans misusing prescription drugs. Suncoast Rehab backs the NCPA in their efforts, and says that communities must take it one step further in fighting this epidemic. Spring Hill, FL (PRWEB) September 03, 2014 One in four Americans are affected by prescription drug abuse. (1) This growing national epidemic kills more people annually...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'